Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Version history
  • Article usage
  • Citations to this article (30)

Advertisement

Research Article Free access | 10.1172/JCI102184

CHLORAMPHENICOL (CHLOROMYCETIN), AN ANTIBIOTIC. PHARMACOLOGICAL AND PATHOLOGICAL STUDIES IN ANIMALS

O. M. Gruhzit, R. A. Fisken, T. F. Reutner, and Edith Martino

Research Laboratories, Parke, Davis and Company, Detroit, Michigan

1

Presented at the Second National Symposium on Recent Advances in Antibiotics Research held in Washington, D. C., April 11-12, 1949, under the auspices of the Antibiotics Study Section, National Institutes of Health, Public Health Service, Federal Security Agency.

2

Chloramphenicol is a generic name coined from the chemical structure of the compound.

3

Chloromycetin is a designated trade mark under which it was originally studied in the laboratory.

Find articles by Gruhzit, O. in: PubMed | Google Scholar

Research Laboratories, Parke, Davis and Company, Detroit, Michigan

1

Presented at the Second National Symposium on Recent Advances in Antibiotics Research held in Washington, D. C., April 11-12, 1949, under the auspices of the Antibiotics Study Section, National Institutes of Health, Public Health Service, Federal Security Agency.

2

Chloramphenicol is a generic name coined from the chemical structure of the compound.

3

Chloromycetin is a designated trade mark under which it was originally studied in the laboratory.

Find articles by Fisken, R. in: PubMed | Google Scholar

Research Laboratories, Parke, Davis and Company, Detroit, Michigan

1

Presented at the Second National Symposium on Recent Advances in Antibiotics Research held in Washington, D. C., April 11-12, 1949, under the auspices of the Antibiotics Study Section, National Institutes of Health, Public Health Service, Federal Security Agency.

2

Chloramphenicol is a generic name coined from the chemical structure of the compound.

3

Chloromycetin is a designated trade mark under which it was originally studied in the laboratory.

Find articles by Reutner, T. in: PubMed | Google Scholar

Research Laboratories, Parke, Davis and Company, Detroit, Michigan

1

Presented at the Second National Symposium on Recent Advances in Antibiotics Research held in Washington, D. C., April 11-12, 1949, under the auspices of the Antibiotics Study Section, National Institutes of Health, Public Health Service, Federal Security Agency.

2

Chloramphenicol is a generic name coined from the chemical structure of the compound.

3

Chloromycetin is a designated trade mark under which it was originally studied in the laboratory.

Find articles by Martino, E. in: PubMed | Google Scholar

Published September 1, 1949 - More info

Published in Volume 28, Issue 5 on September 1, 1949
J Clin Invest. 1949;28(5):943–952. https://doi.org/10.1172/JCI102184.
© 1949 The American Society for Clinical Investigation
Published September 1, 1949 - Version history
View PDF
Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 943
page 943
icon of scanned page 944
page 944
icon of scanned page 945
page 945
icon of scanned page 946
page 946
icon of scanned page 947
page 947
icon of scanned page 948
page 948
icon of scanned page 949
page 949
icon of scanned page 950
page 950
icon of scanned page 951
page 951
icon of scanned page 952
page 952
Version history
  • Version 1 (September 1, 1949): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article (30)

Go to

  • Top
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts